临床综述154：药物治疗在肢端肥大症患者围手术期管理中的作用。 - Suppr

Clinical review 154: The role of pharmacotherapy in perioperative management of patients with acromegaly.

作者信息

Ben-Shlomo Anat, Melmed Shlomo

机构信息

Cedars-Sinai Research Institute, University of California Los Angeles School of Medicine, Los Angeles, California 90048, USA.

出版信息

J Clin Endocrinol Metab. 2003 Mar;88(3):963-8. doi: 10.1210/jc.2002-020072.

DOI:10.1210/jc.2002-020072

PMID:12629068

Abstract

摘要

相似文献

Clinical review 154: The role of pharmacotherapy in perioperative management of patients with acromegaly.

J Clin Endocrinol Metab. 2003 Mar;88(3):963-8. doi: 10.1210/jc.2002-020072.

Medical treatment of acromegaly: comorbidities and their reversibility by somatostatin analogs.

Neuroendocrinology. 2006;83(3-4):249-57. doi: 10.1159/000095535. Epub 2006 Oct 13.

Somatostatin agonists for treatment of acromegaly.

Mol Cell Endocrinol. 2008 May 14;286(1-2):192-8. doi: 10.1016/j.mce.2007.11.024. Epub 2007 Nov 29.

Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly.

J Clin Endocrinol Metab. 2006 Jan;91(1):85-92. doi: 10.1210/jc.2005-1208. Epub 2005 Nov 1.

Somatostatin analogs in acromegaly.

J Clin Endocrinol Metab. 2002 Jul;87(7):3013-8. doi: 10.1210/jcem.87.7.8665.

Normal Insulin-like Growth Factor 1 During Somatostatin Receptor Ligand Treatment Predicts Surgical Cure in Acromegaly.

J Clin Endocrinol Metab. 2020 Sep 1;105(9). doi: 10.1210/clinem/dgaa424.

Long-term primary medical therapy with somatostatin analogs in acromegaly.

J Formos Med Assoc. 2006 Aug;105(8):664-9. doi: 10.1016/S0929-6646(09)60166-2.

Newer options in the management of acromegaly.

Intern Med J. 2006 Jul;36(7):437-44. doi: 10.1111/j.1445-5994.2006.01097.x.

Efficacy and limits of somatostatin analogs.

J Endocrinol Invest. 2005;28(11 Suppl International):53-7.

Predictors of tumor shrinkage after primary therapy with somatostatin analogs in acromegaly: a prospective study in 99 patients.

J Clin Endocrinol Metab. 2006 Jun;91(6):2112-8. doi: 10.1210/jc.2005-2110. Epub 2006 Mar 14.

引用本文的文献

Acromegaly and COVID-19, lessons, and new opportunities.

Pituitary. 2024 Dec;27(6):935-944. doi: 10.1007/s11102-024-01404-0. Epub 2024 May 31.

Surgical and non-surgical interventions for primary and salvage treatment of growth hormone-secreting pituitary adenomas in adults.

Cochrane Database Syst Rev. 2024 Feb 6;2(2):CD013561. doi: 10.1002/14651858.CD013561.pub2.

Preoperative Medical Treatment for Patients With Acromegaly: Yes or No?

J Endocr Soc. 2022 Aug 4;6(9):bvac114. doi: 10.1210/jendso/bvac114. eCollection 2022 Sep 1.

Editorial: New Trends and Approaches in Perioperative Pharmacotherapy: An Update.

Front Pharmacol. 2021 Aug 6;12:721075. doi: 10.3389/fphar.2021.721075. eCollection 2021.

Successful Primary Medical Therapy with Somatostatin Receptor Ligand in Acromegaly with Thyroid Cancer.

J ASEAN Fed Endocr Soc. 2017;32(2):169-172. doi: 10.15605/jafes.032.02.12. Epub 2017 Sep 30.

Pre-surgical medical treatment, a major prognostic factor for long-term remission in acromegaly.

Pituitary. 2018 Dec;21(6):615-623. doi: 10.1007/s11102-018-0916-0.

The effect of albumin fusion structure on the production and bioactivity of the somatostatin-28 fusion protein in Pichia pastoris.

J Ind Microbiol Biotechnol. 2014 Jun;41(6):997-1006. doi: 10.1007/s10295-014-1440-5. Epub 2014 Apr 22.

Clinical applications of somatostatin analogs for growth hormone-secreting pituitary adenomas.

Patient Prefer Adherence. 2014 Jan 6;8:43-51. doi: 10.2147/PPA.S53930.

Medical therapy of acromegaly.

Int J Endocrinol. 2012;2012:268957. doi: 10.1155/2012/268957. Epub 2012 Apr 10.

Acromegaly.

Endocrinol Metab Clin North Am. 2008 Mar;37(1):101-22, viii. doi: 10.1016/j.ecl.2007.10.002.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Clinical review 154: The role of pharmacotherapy in perioperative management of patients with acromegaly.

J Clin Endocrinol Metab. 2003 Mar;88(3):963-8. doi: 10.1210/jc.2002-020072.

Medical treatment of acromegaly: comorbidities and their reversibility by somatostatin analogs.

Neuroendocrinology. 2006;83(3-4):249-57. doi: 10.1159/000095535. Epub 2006 Oct 13.

Somatostatin agonists for treatment of acromegaly.

Mol Cell Endocrinol. 2008 May 14;286(1-2):192-8. doi: 10.1016/j.mce.2007.11.024. Epub 2007 Nov 29.

Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly.

J Clin Endocrinol Metab. 2006 Jan;91(1):85-92. doi: 10.1210/jc.2005-1208. Epub 2005 Nov 1.

Somatostatin analogs in acromegaly.

J Clin Endocrinol Metab. 2002 Jul;87(7):3013-8. doi: 10.1210/jcem.87.7.8665.

Normal Insulin-like Growth Factor 1 During Somatostatin Receptor Ligand Treatment Predicts Surgical Cure in Acromegaly.

J Clin Endocrinol Metab. 2020 Sep 1;105(9). doi: 10.1210/clinem/dgaa424.

Long-term primary medical therapy with somatostatin analogs in acromegaly.

J Formos Med Assoc. 2006 Aug;105(8):664-9. doi: 10.1016/S0929-6646(09)60166-2.

Newer options in the management of acromegaly.

Intern Med J. 2006 Jul;36(7):437-44. doi: 10.1111/j.1445-5994.2006.01097.x.

Efficacy and limits of somatostatin analogs.

J Endocrinol Invest. 2005;28(11 Suppl International):53-7.

Predictors of tumor shrinkage after primary therapy with somatostatin analogs in acromegaly: a prospective study in 99 patients.

J Clin Endocrinol Metab. 2006 Jun;91(6):2112-8. doi: 10.1210/jc.2005-2110. Epub 2006 Mar 14.

引用本文的文献

Acromegaly and COVID-19, lessons, and new opportunities.

Pituitary. 2024 Dec;27(6):935-944. doi: 10.1007/s11102-024-01404-0. Epub 2024 May 31.

Surgical and non-surgical interventions for primary and salvage treatment of growth hormone-secreting pituitary adenomas in adults.

Cochrane Database Syst Rev. 2024 Feb 6;2(2):CD013561. doi: 10.1002/14651858.CD013561.pub2.

Preoperative Medical Treatment for Patients With Acromegaly: Yes or No?

J Endocr Soc. 2022 Aug 4;6(9):bvac114. doi: 10.1210/jendso/bvac114. eCollection 2022 Sep 1.

Editorial: New Trends and Approaches in Perioperative Pharmacotherapy: An Update.

Front Pharmacol. 2021 Aug 6;12:721075. doi: 10.3389/fphar.2021.721075. eCollection 2021.

Successful Primary Medical Therapy with Somatostatin Receptor Ligand in Acromegaly with Thyroid Cancer.

J ASEAN Fed Endocr Soc. 2017;32(2):169-172. doi: 10.15605/jafes.032.02.12. Epub 2017 Sep 30.

Pre-surgical medical treatment, a major prognostic factor for long-term remission in acromegaly.

Pituitary. 2018 Dec;21(6):615-623. doi: 10.1007/s11102-018-0916-0.

The effect of albumin fusion structure on the production and bioactivity of the somatostatin-28 fusion protein in Pichia pastoris.

J Ind Microbiol Biotechnol. 2014 Jun;41(6):997-1006. doi: 10.1007/s10295-014-1440-5. Epub 2014 Apr 22.

Clinical applications of somatostatin analogs for growth hormone-secreting pituitary adenomas.

Patient Prefer Adherence. 2014 Jan 6;8:43-51. doi: 10.2147/PPA.S53930.

Medical therapy of acromegaly.

Int J Endocrinol. 2012;2012:268957. doi: 10.1155/2012/268957. Epub 2012 Apr 10.

Acromegaly.

Endocrinol Metab Clin North Am. 2008 Mar;37(1):101-22, viii. doi: 10.1016/j.ecl.2007.10.002.

Clinical review 154: The role of pharmacotherapy in perioperative management of patients with acromegaly.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献